{
    "code": "01021189",
    "url": "https:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=01021189",
    "time": "2019-06-14 03:15:28",
    "許可證字號": "衛署藥製字第021189號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "有效日期": "113\/05\/25",
    "發證日期": "69\/04\/11",
    "許可證種類": "製　劑",
    "舊證字號": "00000000",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHY00102118900",
    "中文品名": "別吐注射液（美托拉麥）",
    "英文品名": "METOCLOPRAMIDE INJECTION &quot;LITA&quot;",
    "適應症": "預防嘔吐、逆流性消化性食道炎、糖尿病引起之胃腸蠕動異常。",
    "劑型": "270注射劑",
    "包裝": "2毫升，100支以下盒裝安瓿",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": [
        ""
    ],
    "藥品類別": "05限由醫師使用",
    "主成分略述": "METOCLOPRAMIDE HCL",
    "主製造廠": {
        "申請商名稱": "0701010200  利達製藥股份有限公司",
        "申請商地址": "台中市大甲區中山路一段９０６號",
        "主製造廠": "",
        "製造廠名稱": "6105200026  瑞士藥廠股份有限公司新市廠"
    },
    "CCC號列": "30049099904 其他醫藥製劑〈不包括第３００２、３００５或３００６節所列者〉包含經混合或未混合產品供治療或預防疾病用，具有劑量（包括經皮給藥形態者）或零售包裝式樣者Other medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "5622000710",
            "成分名稱": "METOCLOPRAMIDE HCL",
            "含量描述": "10",
            "含量": "10.0000000000",
            "單位": "MG"
        }
    ],
    "仿單外盒": [
        {
            "title": "MTA- 別吐說明書-103-09-23.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01021189&Seq=003&Type=9"
        },
        {
            "title": "MTA瓶標-103-09-23.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01021189&Seq=003&Type=8"
        }
    ]
}